10:44 ET Volume Leader #28 - VRX 4,448,124 Valeant

All Eyes on Ares – From the Trading Floor to Barclays Nothing like the crisp snap of traders' attention when big players like Ares Management Corporation (NYSE:ARES) are set to spill some beans at a fancy conference. Come September 16, 2026, Ares' head honcho, Michael Arougheti, will be hitting the stage at the Barclays Global Financial Services Conference. It’s the...

Boosting Connectivity for Student-Athletes Here's a nugget that slips under the radar unless you're looking with both eyes open: Scientel Solutions, from Aurora, Illinois, is shaking up the connectivity game for North Central College's athletic department. These folks have realized something many don't quite grasp—keeping student-athletes connected is no luxury; it's...

A Cosmic Coin Collection for the Ages The Royal Mint has stepped boldly into a realm where no coin has gone before—celebrating six decades of Star Trek with two new collectable 50p coins. For Star Trek fans who’ve followed the Enterprise to the furthest reaches of the galaxy, these coins aren’t just chump change—they’re keepsakes that capture a piece of sci-fi...

Transforming Fields with a Bird's Eye View The old-school way of agricultural surveying is about as appealing as a broken plow in a rainstorm. Trudging across miles of farmland, hoping to spot issues before they turn into wallet-drainers—who's got time for that? Enter drones, the buzzing saviors of the modern farm. These high-tech marvels, loaded with multispectral and...

Shifting Gears: Gan & Lee's Major European Play Picture it—Asian biopharma juggernaut Gan & Lee Pharmaceuticals is hitching a ride with Europe's Menarini Group to take its flagship, bofanglutide, across the vast European market. It's a move that's got shades of grand ambition, colorful strategy, and not a small sum riding on its success. Cracking the Metabolic Code The...

Changing the Game in Power Generation In the ever-shifting landscape of power generation, having a seasoned player at the helm can be the difference between stagnation and growth. FirstEnergy Corp. (NYSE:FE) has tapped Jon Dormo as its Vice President of Generation Project Development. The mission? Overhaul and expand projects to meet the increasing demands for...

Timber Talk with Wes McAdams Diving into the nitty-gritty of building materials isn't everyone's cup of tea, but when you live in a place like Baton Rouge, understanding what stands up to the swampy summer heat is plain survival. The main focus? Cypress wood. Now, Wes McAdams from Cajun Cypress throws his hat into the ring, shedding some light on why cypress might just be...

Meet “Tahoe Truckee Life” Kane Schaller, the face of the Tahoe Truckee Life series, is giving folks a front-row seat to the lives and landscapes that make the Reno-Tahoe region buzz. Now, I've seen shows trying to pull this off, but this one might just spark something genuine if done right. The Real Deal on Reno-Tahoe The show airs on the REAL Shows Network—a...

Unpacking the Ambitious 90-Day Plan When you hear Vishal Garg's name next to a 90-day sprint plan, it's not your everyday boardroom shuffle—you know there's grit behind the screen. Better Home & Finance (BETR) is angling for a massive turnaround with its latest rollout, but whether it's all sizzle and no steak is what we're here to figure out. Financial Metrics and...

Why This Collaboration Matters Here comes an interesting tidbit from the world of cytology: Hamamatsu and AIxMed are banding together to tackle workflow inefficiencies. Picture this—two powerhouses coming together to create a tool that might just relieve lab technicians from the tedious task of manually checking cytology slides. In a world where efficiency is king, this...

Overview of MoonLake Immunotherapeutics Class Action Investors in MoonLake Immunotherapeutics (NASDAQ: MLTX) have recently found themselves facing significant challenges. The disclosures regarding the company’s operations and the marketing of its products have prompted questions about the integrity of the information provided to shareholders. Why a Class Action? In a...

BioCryst Concludes Successful Sale of European ORLADEYO Business In a significant move, BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) has confirmed the successful sale of its European ORLADEYO business to Neopharmed Gentili. This transaction is valued at $250 million and includes the potential for up to $14 million in future milestones linked to sales across Central and...

Overview of Investor Rights in the Edwards Lifesciences Case In today's financial landscape, safeguarding your investments is paramount. Edwards Lifesciences Corporation (NYSE: EW) has emerged as a notable player in the healthcare sector, particularly in innovative heart valve therapies. However, recent events have raised concerns among shareholders, prompting calls for...

Revolutionizing Radiotherapy with Accuray Stellar Accuray, a leader in adaptive radiotherapy, has launched the Accuray Stellar™ Solution, which is designed to transform cancer care. This innovative solution offers an expansive toolbox that empowers clinical teams to adapt treatments to fit each patient's unique needs. Accuray's commitment to enhancing radiotherapy...

Scale Computing Shines on Prestigious AI 100 Awards List Scale Computing, the market leader in edge computing and hyperconverged solutions, has recently made waves in the tech industry by being recognized on the annual CRN AI 100 list. This list marks a milestone as it celebrates companies that are at the forefront of innovation in artificial intelligence. Understanding...